H

ello, everyone, and how are you today? We are doing just fine, thank you, despite the gloomy clouds hovering over the Pharmalot campus. Sunny spirts are in order because, as the Morning Mayor schooled us: Every brand new day should be unwrapped like a precious gift. Words to live by, yes? While you think it over, please join us for yet another delicious cup of stimulation. And of course, here are your tidbits. Have a wonderful day and do keep in touch …

Allergan (AGN) chief executive officer Brent Saunders told Mad Money there has been “a lot of misunderstanding” about the controversial deal to transfer Restasis patent rights to the St. Regis Mohawk tribe. “It wasn’t desperation, it was tenacity. … And I think people got confused that said because I believe in strong intellectual property, I don’t believe in making medicines affordable and accessible, and one has nothing to do with the other.”

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy